RNS Number : 9274Z

Deutsche Bank AG, Frankfurt

18 May 2023

18 May 2023

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful

Cheplapharm Arzneimittel GmbH
Post-Stabilisation Notice

Pursuant to Article 6(3) of Commission Delegated Regulation (EU) 2016/1052 supplementing Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation, Deutsche Bank Aktiengesellschaft (contact: Jeremy Selway, telephone +44 (0)20 7547 5983) hereby gives notice that stabilisation was undertaken by the Stabilising Manager named below in relation to the offer of the following securities.

The Securities:

Issuer:                                     Cheplapharm Arzneimittel GmbH

Guarantor (if any):                  CheplaFinance 2 GmbH (with limited recourse)

                                                If Cheplapharm Switzerland will acquire some or all of the assets                                        subject to the Izac Acquisition, as of the Escrow Release Date,                                           the Notes will, subject to certain agreed security principles, also                                          be guaranteed on a senior basis by Cheplapharm Switzerland.

Aggregate nominal amount:   EUR 425.000.000

Description:                            EUR 425,000,000 Senior Secured Notes7.50% due 2030                                                     (RegS ISIN: XS2618867159; 144A ISIN: XS2618869445)

Issue/Reoffer Price:                100

Spread over benchmark:        +523 bps

Trading venue(s) on which stabilisation occurred:  The International Stock Exchange Authority Limited

Stabilisation:

Stabilising Manager(s):              Deutsche Bank Aktiengesellschaft

Stabilisation started:                  26 April 2023

Stabilisation last occurred:         02 May 2023

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

Date:	Lowest Price (EUR):	Highest Price (EUR):
24/04/2023	100.125	100.125
27/04/2023	100.375	100.375
28/04/2023	100.375	100.625
02/05/2023	100.625	100.625

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

STAFLFLFELITLIV